These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 33580918)

  • 1. Severe adverse events during sirolimus "off-label" therapy for vascular anomalies.
    Rössler J; Baselga E; Davila V; Celis V; Diociaiuti A; El Hachem M; Mestre S; Haeberli D; Prokop A; Hanke C; Loichinger W; Quéré I; Baumgartner I; Niemeyer CM; Kapp FG
    Pediatr Blood Cancer; 2021 Aug; 68(8):e28936. PubMed ID: 33580918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus in the Treatment of Vascular Anomalies.
    Triana P; Dore M; Cerezo VN; Cervantes M; Sánchez AV; Ferrero MM; González MD; Lopez-Gutierrez JC
    Eur J Pediatr Surg; 2017 Feb; 27(1):86-90. PubMed ID: 27723921
    [No Abstract]   [Full Text] [Related]  

  • 3. Sirolimus as initial therapy for kaposiform hemangioendothelioma and tufted angioma.
    Wang H; Guo X; Duan Y; Zheng B; Gao Y
    Pediatr Dermatol; 2018 Sep; 35(5):635-638. PubMed ID: 29999213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies.
    Ozeki M; Nozawa A; Yasue S; Endo S; Asada R; Hashimoto H; Fukao T
    Orphanet J Rare Dis; 2019 Jun; 14(1):141. PubMed ID: 31196128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular Anomalies: Diagnosis of Complicated Anomalies and New Medical Treatment Options.
    Adams DM; Ricci KW
    Hematol Oncol Clin North Am; 2019 Jun; 33(3):455-470. PubMed ID: 31030813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus for the treatment of children with various complicated vascular anomalies.
    Lackner H; Karastaneva A; Schwinger W; Benesch M; Sovinz P; Seidel M; Sperl D; Lanz S; Haxhija E; Reiterer F; Sorantin E; Urban CE
    Eur J Pediatr; 2015 Dec; 174(12):1579-84. PubMed ID: 26040705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham-Stout disease.
    Ricci KW; Hammill AM; Mobberley-Schuman P; Nelson SC; Blatt J; Bender JLG; McCuaig CC; Synakiewicz A; Frieden IJ; Adams DM
    Pediatr Blood Cancer; 2019 May; 66(5):e27614. PubMed ID: 30672136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus (Rapamycin) for Slow-Flow Malformations in Children: The Observational-Phase Randomized Clinical PERFORMUS Trial.
    Maruani A; Tavernier E; Boccara O; Mazereeuw-Hautier J; Leducq S; Bessis D; Guibaud L; Vabres P; Carmignac V; Mallet S; Barbarot S; Chiaverini C; Droitcourt C; Bursztejn AC; Lengellé C; Woillard JB; Herbreteau D; Le Touze A; Joly A; Léauté-Labrèze C; Powell J; Bourgoin H; Gissot V; Giraudeau B; Morel B
    JAMA Dermatol; 2021 Nov; 157(11):1289-1298. PubMed ID: 34524406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and absorption of topical sirolimus for the treatment of vascular anomalies in children: A case series.
    Le Sage S; David M; Dubois J; Powell J; McCuaig CC; Théorêt Y; Kleiber N
    Pediatr Dermatol; 2018 Jul; 35(4):472-477. PubMed ID: 29790593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of superficial vascular anomalies with topical sirolimus: A multicenter case series.
    Dodds M; Tollefson M; Castelo-Soccio L; Garzon MC; Hogeling M; Hook K; Boull C; Maguiness S
    Pediatr Dermatol; 2020 Mar; 37(2):272-277. PubMed ID: 31957126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Our experience with sirolimus for the treatment of complicated vascular anomalies].
    Giménez-Aleixandre C; Méndez-Aguirre NA; Martínez-Menchón T; Girón Vallejo Ó; Fernández-Ibieta M; Ferri-Ñíguez B; Villamil V; Sánchez-Sánchez Á; Montoya-Rangel CA; Hernández-Bermejo JP
    Cir Pediatr; 2019 Jan; 32(1):28-33. PubMed ID: 30714698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirolimus for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon in Two Infants.
    Wang Y; Kong L; Sun B; Cui J; Shen W
    J Craniofac Surg; 2020 Jun; 31(4):1074-1077. PubMed ID: 32176003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathologic study of pediatric vascular anomalies: a report of 117 cases].
    Niu HL; Zhou SY; Lin QQ; Yi P; Wang FH; Gao Q; Chen ZR; Xia JQ; Zheng HC; Zeng RX
    Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):252-7. PubMed ID: 27033389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Sirolimus: An Option in the Management of Neonates with Life-Threatening Upper Airway Lymphatic Malformations.
    Triana P; Miguel M; Díaz M; Cabrera M; López Gutiérrez JC
    Lymphat Res Biol; 2019 Oct; 17(5):504-511. PubMed ID: 30985248
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of kaposiform lymphangiomatosis with sirolimus.
    Wang Z; Li K; Yao W; Dong K; Xiao X; Zheng S
    Pediatr Blood Cancer; 2015 Jul; 62(7):1291-3. PubMed ID: 25598153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective multicenter study of sirolimus for complicated vascular anomalies.
    Ji Y; Chen S; Yang K; Zhou J; Zhang X; Jiang X; Xu X; Lu G; Qiu L; Kong F; Zhang Y
    J Vasc Surg; 2021 Nov; 74(5):1673-1681.e3. PubMed ID: 34082006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of sirolimus in the treatment of vascular anomalies: A systematic review.
    Freixo C; Ferreira V; Martins J; Almeida R; Caldeira D; Rosa M; Costa J; Ferreira J
    J Vasc Surg; 2020 Jan; 71(1):318-327. PubMed ID: 31676179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
    Ji Y; Chen S; Xiang B; Li K; Xu Z; Yao W; Lu G; Liu X; Xia C; Wang Q; Li Y; Wang C; Yang K; Yang G; Tang X; Xu T; Wu H
    Int J Cancer; 2017 Aug; 141(4):848-855. PubMed ID: 28486787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus.
    Cashell J; Smink GM; Helm K; Xavier F
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27305. PubMed ID: 30070028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indications and Limitations of Sirolimus in the Treatment of Vascular Anomalies-Insights From a Retrospective Case Series.
    Karastaneva A; Gasparella P; Tschauner S; Crazzolara R; Kropshofer G; Modl M; Pfleger A; Burmas A; Pocivalnik M; Ulreich R; Zenz W; Schwinger W; Beqo BP; Urban C; Haxhija EQ; Lackner H; Benesch M
    Front Pediatr; 2022; 10():857436. PubMed ID: 35676905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.